315 related articles for article (PubMed ID: 20109651)
21. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE
Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
[TBL] [Abstract][Full Text] [Related]
22. Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.
Elliott BM; Aledort LM
Expert Rev Hematol; 2013 Jun; 6(3):277-86. PubMed ID: 23782082
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
[TBL] [Abstract][Full Text] [Related]
24. Dysfibrinogenemia and thrombosis.
Mosesson MW
Semin Thromb Hemost; 1999; 25(3):311-9. PubMed ID: 10443961
[TBL] [Abstract][Full Text] [Related]
25. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.
Casini A; Neerman-Arbez M; Ariëns RA; de Moerloose P
J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717
[TBL] [Abstract][Full Text] [Related]
26. [Whether fibrinogen concentrates are necessary in Russia?].
Galstian GM; Berkovskiĭ AL; Zhuravlev VV; Polokhov DM; Savchenko VG
Anesteziol Reanimatol; 2014; (3):49-59. PubMed ID: 25306685
[TBL] [Abstract][Full Text] [Related]
27. Congenital dysfibrinogenemia.
Martinez J
Curr Opin Hematol; 1997 Sep; 4(5):357-65. PubMed ID: 9288470
[TBL] [Abstract][Full Text] [Related]
28. The dilemma of inherited dysfibrinogenemia during pregnancy.
Munoz J; Schering J; Lambing A; Neal S; Goyert G; Green PM; Hanbali A; Raman S; Kuriakose P
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):775-7. PubMed ID: 23135383
[TBL] [Abstract][Full Text] [Related]
29. Congenital structural and functional fibrinogen disorders: a primer for internists.
Undas A; Casini A
Pol Arch Intern Med; 2019 Dec; 129(12):913-920. PubMed ID: 31797863
[TBL] [Abstract][Full Text] [Related]
30. Congenital fibrinogen disorders with repeated thrombosis.
Zhang X; Zhang C; Wang B; Chen N; Sun G; Guo X
J Thromb Thrombolysis; 2020 Feb; 49(2):312-315. PubMed ID: 31542854
[TBL] [Abstract][Full Text] [Related]
31. Clinical Features and Management of Congenital Fibrinogen Deficiencies.
Casini A; de Moerloose P; Neerman-Arbez M
Semin Thromb Hemost; 2016 Jun; 42(4):366-74. PubMed ID: 27019462
[TBL] [Abstract][Full Text] [Related]
32. Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen.
Casini A; Abdul Kadir R; Abdelwahab M; Manco-Johnson MJ; Raut S; Ross C; de Moerloose P; Santoro C; Acharya S
J Thromb Haemost; 2024 May; 22(5):1516-1521. PubMed ID: 38266678
[TBL] [Abstract][Full Text] [Related]
33. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA).
Marchi R; Carvajal Z; Meyer M; Soria J; Ruiz-Saez A; Arocha-Piñango CL; Weisel JW
Thromb Res; 2006; 118(5):637-50. PubMed ID: 16406498
[TBL] [Abstract][Full Text] [Related]
34. Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review.
Li Y; Ding B; Wang X; Ding Q
Thromb Res; 2022 Sep; 217():36-47. PubMed ID: 35853369
[TBL] [Abstract][Full Text] [Related]
35. [Case report of congenital afibrinogenemia].
Leeners JV; Mossakowski J; Kayser S
Klin Padiatr; 1995; 207(1):34-5. PubMed ID: 7885016
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).
de Bosch NB; Mosesson MW; Ruiz-Sáez A; Echenagucia M; Rodriguez-Lemoin A
Thromb Haemost; 2002 Aug; 88(2):253-8. PubMed ID: 12195697
[TBL] [Abstract][Full Text] [Related]
37. Congenital dysfibrinogenemias. A review.
Rocha E; Páramo JA; Aranda A; Cuesta B; Fernández J
Ric Clin Lab; 1985; 15(3):205-29. PubMed ID: 3909359
[TBL] [Abstract][Full Text] [Related]
38. [Fibrinogen substitution. Use in the treatment of bleeding due to lack of fibrinogen].
Ingerslev J; Sørensen B
Ugeskr Laeger; 2005 Jun; 167(25-31):2759-61. PubMed ID: 16014260
[TBL] [Abstract][Full Text] [Related]
39. Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management.
Simurda T; Asselta R; Zolkova J; Brunclikova M; Dobrotova M; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829490
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen concentrate for acquired hypofibrinogenaemic states.
Weinkove R; Rangarajan S
Transfus Med; 2008 Jun; 18(3):151-7. PubMed ID: 18598277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
